Literature DB >> 15238467

Approach to "aspirin allergy" in cardiovascular patients.

Srinivasan Ramanuja1, Jeffrey A Breall, Vijay G Kalaria.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15238467     DOI： 10.1161/01.CIR.0000134306.28561.2A

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

Review 1.  Aspirin allergy desensitization in cerebrovascular disease. A report of two cases, literature review and management guide for the neurointerventionalist.

Authors:  Scott L Zuckerman; David B Seder; Crystiana Tsujiura; Deborah Cushing; Holly Gallup; J Mocco; Richard A Hanel; Robert D Ecker
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

Review 2.  Aspirin hypersensitivity and desensitization protocols: implications for cardiac patients.

Authors:  Phil Lambrakis; Gordon F Rushworth; Jane Adamson; Stephen J Leslie
Journal:  Ther Adv Drug Saf       Date:  2011-12

3.  Myocardial infarction after aspirin treatment.

Authors:  David J Fox; Timothy P Gray; Farzin Fath-Ordoubadi
Journal:  J R Soc Med       Date:  2005-01       Impact factor: 18.000

Review 4.  Asthma and stroke: a narrative review.

Authors:  A Corlateanu; Iu Stratan; S Covantev; V Botnaru; O Corlateanu; N Siafakas
Journal:  Asthma Res Pract       Date:  2021-02-19

Review 5.  Coronary Artery Disease and Aspirin Intolerance: Background and Insights on Current Management.

Authors:  Ravi A Thakker; Leonardo Salazar; Deaa Abu Jazar; Pooja Bhakta; Bryan Baker; Chandani Patel; Ayman Elbadawi; Mayank Agarwal; Aiham Albaeni; Mohammed Saleh; Jonathan Esclovan; Danielle El Haddad; Hashim Alwash; Ankur Kalra; Sachin S Goel; Robert Jay Widmer; Khaled Chatila; Wissam Khalife; Afaq Motiwala; Jennifer McCracken; Hani Jneid; Syed Gilani
Journal:  Cardiol Ther       Date:  2022-03-28

Review 6.  Aspirin and nonsteroidal anti-inflammatory drug hypersensitivity.

Authors:  James S W Kong; Suzanne S Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.